ArticleRadiation and environmental biophysics2025
Comparative dosimetric assessment of combined treatment modalities in cervical cancer radiotherapy for optimal organ protection.
Article in Radiation and environmental biophysics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
External radiotherapy combined with internal radiotherapy in cervical cancer can provide a boost to the target volume to increase tumour control. At the same time internal radiotherapy protects neighboring organs. The aim of the present study was to dosimetrically compare three external beam radiotherapy techniques each combined with internal radiotherapy to evaluate the combination that offers the best organ protection. Treatment plans of 20 cervical cancer patients were created for external (including three-dimensional conformal radiotherapy (3D-CRT), intensity modulated radiotherapy (IMRT) and volumetric modulated arc therapy (VMAT)) as well as brachytherapy. The prescribed dose was 50 Gy in 25 fractions for external and 21 Gy in three fractions for internal radiotherapy. The following organs at risk (OARs) were evaluated: bladder, rectum, sigmoid and bowel bag. The study analyzed the results of different treatment combinations in terms of dosimetric values for various parameters. The D
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.